T Cell News and Research

Latest T Cell News and Research

New treatment options for leukemia and myeloproliferative disorders introduced

Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology introduces potential new treatment options and improved diagnostic methods for patients suffering from acute promyelocytic leukemia, chronic myeloid leukemia, infant acute lymphoblastic leukemia, and myelofibrosis that are based on a better understanding of the underlying genetic causes of these conditions.

6 Dec 2009

Health experts available to discuss health care reform

Edward D. Miller was named chief executive officer of Johns Hopkins Medicine, the 13th dean of The Johns Hopkins University School of Medicine and vice president for medicine of The Johns Hopkins University in January 1997.

5 Dec 2009

Critical enzyme activity provides new insight into heart disease mechanisms

Using a new mathematical model of heart cells, University of Iowa investigators have shown how activation of a critical enzyme, calmodulin kinase II (CaM kinase), disrupts the electrical activity of heart cells.

5 Dec 2009

Study on fruit flies may help in understanding the root cause of stem cell diseases

The body is a battle zone. Cells constantly compete with one another for space and dominance. Though the manner in which some cells win this competition is well known to be the survival of the fittest, how stem cells duke it out for space and survival is not as clear.

5 Dec 2009

Health experts available to speak about health care reform

Garson helped originate and draft the "Health Partnership Act" (S. 325 and H.R. 5606), which funds grants to states for innovations to improve coverage for the uninsured, quality and efficiency.

5 Dec 2009

Emerging Healthcare Solutions enters into discussions with a Houston-based medical company

Emerging Healthcare Solutions, Inc. today announced the Company has entered into discussions with a Houston-based medical company relating to its patented, and patent pending, genetics technologies.

5 Dec 2009

Environmental sensors may help avoid air pollution hot spots in everyday life

You want to go for a run, but you don't want to run in polluted air that might aggravate your asthma. University of California, San Diego computer scientists are creating a network of environmental sensors that will help you avoid air pollution hot spots that exist exactly when you are planning your route.

5 Dec 2009

Statins may protect against GVHD complications

Cholesterol-lowering drugs known as statins are among the most prescribed medicines in the U.S. Now a new study by researchers at Fred Hutchinson Cancer Research Center indicates that statins may protect stem cell transplant patients from one of the most serious complications of the life-saving cancer therapy: graft-versus-host disease, or GVHD.

5 Dec 2009

'Twist' gene plays a key role in the development of breast cancer

Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accurately distinguish stem cells that drive aggressive, metastatic breast cancer from other breast cancer cells.

5 Dec 2009

Statins may help protect stem cell transplant patients from GVHD

5 Dec 2009

DTI helps identify distorted nerve fiber bundles around brain tumors in thalamic JPA children

A new study published this week in the Journal of Neurosurgery: Pediatrics finds that operative plans for removing Juvenile Pilocytic Astrocytoma, or JPA, tumors in the thalamus of the brain can be augmented with Diffusion Tensor Imaging, or DTI. The sensitivity of DTI imaging allows for the visualization of nerve fiber bundles in the brain.

5 Dec 2009

Benign tumors in children can be augmented with Diffusion Tensor Imaging

5 Dec 2009

Rituximab drug may reduce long-term complications of type 1 diabetes

New findings by UT Southwestern researchers suggest that a drug already used to treat autoimmune disorders might also help slow the destruction of insulin-producing cells in patients recently diagnosed with insulin-dependent (type 1) diabetes.

4 Dec 2009

Fluxion Biosciences signs distribution agreement with DI Biotech and Novel Science

Fluxion Biosciences announced today that it has expanded its sales and service network into Asia. The company signed a distribution agreement for its BioFlux™ line with Korea-based DI Biotech. A second agreement with Novel Science covers sales of both the BioFlux and IonFlux™ platforms in Japan. Fluxion has also sold its first BioFlux 1000 system into China.

From Fluxion Biosciences 4 Dec 2009

BUSM researchers report an inverse association between dairy intake and fibroid risk

Boston University School of Medicine (BUSM) researchers at the Slone Epidemiology Center found that black women with high intake of dairy products have a reduced incidence of uterine leiomyomata (fibroids). This report, based on the Black Women's Health Study, appears in the current issue of the American Journal of Epidemiology.

4 Dec 2009

Preclinical data of Curis' HSP 90 inhibitor published

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that preclinical data related to CUDC-305, the company’s Heat Shock Protein (HSP) 90 inhibitor, was published online this week in Molecular Cancer Therapeutics.

4 Dec 2009

Allos Therapeutics, Idis collaborate in named patient program for FOLOTYN

Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ (pralatrexate injection) outside of the United States. The U.S. Food and Drug Administration (FDA) has granted accelerated approval for FOLOTYN for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

4 Dec 2009

IMF to stage presentation on multiple myeloma at ASH annual meeting

The International Myeloma Foundation (IMF)—supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians—today said presentations at the annual meeting of the American Society of Hematology (ASH) will cover all stages of multiple myeloma, a major milestone in treating this and related cancers.

4 Dec 2009

MoneyTV features bioengineering and stem cell topics this week

Bioengineering, extracting health products from waste tobacco, stem cells, unemployment, wind energy; this week on MoneyTV, hosted by anchor Donald Baillargeon.

4 Dec 2009

Researchers discover mechanism that explains how chromosomal translocations are not random

Researchers at the UC San Diego School of Medicine have pinpointed a mechanism that may help explain how chromosomal translocations - the supposedly random shuffling of large chunks of DNA that frequently lead to cancer - aren't so random after all. They have developed a model of such chromosomal mix-ups in prostate cancer which indicates that the male sex hormone (androgen) receptor unexpectedly plays a key role in driving specific translocations in the development of cancer.

4 Dec 2009

T Cell News and Research

Latest T Cell News and Research

New treatment options for leukemia and myeloproliferative disorders introduced

Health experts available to discuss health care reform

Critical enzyme activity provides new insight into heart disease mechanisms

Study on fruit flies may help in understanding the root cause of stem cell diseases

Health experts available to speak about health care reform

Emerging Healthcare Solutions enters into discussions with a Houston-based medical company

Environmental sensors may help avoid air pollution hot spots in everyday life

Statins may protect against GVHD complications

'Twist' gene plays a key role in the development of breast cancer

Statins may help protect stem cell transplant patients from GVHD

DTI helps identify distorted nerve fiber bundles around brain tumors in thalamic JPA children

Benign tumors in children can be augmented with Diffusion Tensor Imaging

Rituximab drug may reduce long-term complications of type 1 diabetes

Fluxion Biosciences signs distribution agreement with DI Biotech and Novel Science

BUSM researchers report an inverse association between dairy intake and fibroid risk

Preclinical data of Curis' HSP 90 inhibitor published

Allos Therapeutics, Idis collaborate in named patient program for FOLOTYN

IMF to stage presentation on multiple myeloma at ASH annual meeting

MoneyTV features bioengineering and stem cell topics this week

Researchers discover mechanism that explains how chromosomal translocations are not random

Immunology eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Newsletters you may be interested in